Literature DB >> 27432039

Use of Extracorporeal Membrane Oxygenation for the Treatment of Influenza-Induced Acute Respiratory Distress Syndrome in Immunocompromised Adults.

M Veronica Dioverti1, Kelly A Cawcutt2, Gregory J Schears3, Larry M Baddour2.   

Abstract

Influenza infection in the adult immunocompromised hosts can have severe presentations and rapid progression to lower respiratory tract infection requiring mechanical ventilation, and it even can progress to acute respiratory distress syndrome. Little is known about the role of extracorporeal membrane oxygenation for management in this setting. We present a review of the current literature on the subject.
Copyright © 2016 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute respiratory distress syndrome; Extracorporeal membrane oxygenation; Immunocompromised; Influenza

Mesh:

Year:  2016        PMID: 27432039     DOI: 10.1016/j.amjms.2016.03.021

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  3 in total

Review 1.  Mechanical Ventilation during Extracorporeal Membrane Oxygenation in Patients with Acute Severe Respiratory Failure.

Authors:  Zhongheng Zhang; Wan-Jie Gu; Kun Chen; Hongying Ni
Journal:  Can Respir J       Date:  2017-01-03       Impact factor: 2.409

Review 2.  Auxiliary role of mesenchymal stem cells as regenerative medicine soldiers to attenuate inflammatory processes of severe acute respiratory infections caused by COVID-19.

Authors:  Peyvand Parhizkar Roudsari; Sepideh Alavi-Moghadam; Moloud Payab; Forough Azam Sayahpour; Hamid Reza Aghayan; Parisa Goodarzi; Fereshteh Mohamadi-Jahani; Bagher Larijani; Babak Arjmand
Journal:  Cell Tissue Bank       Date:  2020-06-25       Impact factor: 1.522

3.  Role and Clinical Application of Metagenomic Next-Generation Sequencing in Immunocompromised Patients With Acute Respiratory Failure During Veno-Venous Extracorporeal Membrane Oxygenation.

Authors:  Yang-Chao Zhao; Yan-Zhong Ding; Xi Zhao; Guo-Wei Fu; Ming-Jun Huang; Xing-Xing Li; Qian-Qian Sun; Ya-Bai Kan; Jun Li; Shi-Lei Wang; Wen-Tao Ma; Qin-Fu Xu; Qi-Long Liu; Hong-Bin Li
Journal:  Front Cell Infect Microbiol       Date:  2022-08-12       Impact factor: 6.073

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.